Cor Vasa 2012, 54(9-10):e336-e338 | DOI: 10.1016/j.crvasa.2012.07.001

Permanent pacemaker lead endocarditis due to Staphylococcus hominis and review of the literature

Suleyman Ercana,*, Gokhan Altunbasb, Fethi Yavuza, Vuslat Bosnakc, Vedat Davutoglua
a Departments of Cardiology, Gaziantep University, School of Medicine, Gaziantep, Turkey
b Department of Cardiology, Kilis State Hospital, Kilis, Turkey
c Departments of Infectious Diseases, Gaziantep University, School of Medicine, Gaziantep, Turkey

Use of intracardiac devices for heart diseases is increasing worldwide. One of the important complications of pacemakers is infective endocarditis from the leads as the source. In this case, we report a lead endocarditis caused by Staphylococcus hominis four years after the pacemaker implantation. A 50-year-old diabetic woman, who was implanted a permanent pacemaker four years ago, had complaints of fever and fatigue three months ago. On transesophageal echocardiography (TEE), a mobile mass resembling vegetation on the lead, which was 15×10 mm in diameter, was revealed. At the end of the second week of treatment, fever persisted and markers of inflammation remained elevated. Thus, the patient was referred for surgery, lead was extracted and a new epicardial lead was placed. The culture of the extracted material was positive for Staphylococcus hominis. Antibiotherapy was continued till the end of the postoperative sixth week accordingly. In conclusion, in patients with pacemakers and risk factors for endocarditis, fever must suggest lead endocarditis and TEE must be performed for accurate diagnosis. In addition to appropriate antibiotic therapy, extraction of infected material is needed for the cure.

Klíčová slova: Lead endocarditis; Staphilococcus hominis; Transesophageal echocardiography

Vloženo: 21. červen 2012; Přijato: 11. červenec 2012; Zveřejněno: 1. září 2012  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ercan S, Altunbas G, Yavuz F, Bosnak V, Davutoglu V. Permanent pacemaker lead endocarditis due to Staphylococcus hominis and review of the literature. Cor Vasa. 2012;54(9-10):e336-338. doi: 10.1016/j.crvasa.2012.07.001.
Stáhnout citaci

Reference

  1. R. Banos, J. Gomez, B. Sanchez, et al., Pacemaker lead endocarditis: analysis of 11 cases, Enfermedades Infecciosas y Microbiología Clínica 18 (2000) 267-270. Přejít na PubMed...
  2. G. Bluhm, I. Julander, M. Lavander-Lindgren, C. Olin, Septicemia and endocarditis: uncommon but serious complications in connection with permanent cardiac pacing, Scandinavian Journal of Thoracic and Cardiovascular Surgery 16 (1982) 65-70. Přejít k původnímu zdroji...
  3. S. Edelstein, M. Yahalom, Cardiac device-related endocarditis: epidemiology, pathogenesis, diagnosis and treatment - a review. International Journal of Angiology 18 (2009) 167-172. Přejít k původnímu zdroji... Přejít na PubMed...
  4. M. Sunbul, M.K. Demirag, O. Yilmaz, et al., Pacemaker lead endocarditis caused by Staphylococcus hominis, Pacing and Clinical Electrophysiology 29 (2006) 543-545. Přejít k původnímu zdroji... Přejít na PubMed...
  5. M.H. Choo, D.R. Holmes Jr, B.J. Gersh, et al., Permanent pacemaker infections: characterization and management, American Journal of Cardiology 48 (1981) 559-564. Přejít k původnímu zdroji... Přejít na PubMed...
  6. F. Victor, C. DePlace, C. Camus, et al., Pacemaker lead infection, echocardiographic features, management, and outcome, Heart 81 (1999) 82-87. Přejít k původnímu zdroji... Přejít na PubMed...
  7. P. Cacoub, P. Leprince, P. Nataf, et al., Pacemaker infective endocarditis, American Journal of Cardiology 82 (1998) 480-484. Přejít k původnímu zdroji... Přejít na PubMed...
  8. N. Kouvousis, A.G. Lazaros, E.G. Christoforatou, et al., Acremonium species pacemaker site infection, Hellenic Journal of Cardiology 44 (2003) 83-87.
  9. G. Habib, B. Hoen, P. Tornos, et al., 2009, ESC Committee for Practice Guidelines, Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer, European Heart Journal 30 (2009) 2369-2413. Přejít k původnímu zdroji...
  10. E. Athan, V.H. Chu, P. Tattevin, et al., 2012, ICE-PCS investigators, Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices, Journal of the American Medical Association 307 (2012) 1727-1735. Přejít k původnímu zdroji... Přejít na PubMed...




Cor et Vasa

Vstupujete na stránky určené zdravotnickým odborníkům, a nikoli laické veřejnosti. Stránky mohou obsahovat také informace, které jsou určeny pouze osobám oprávněným předepisovat a vydávat humánní léčivé přípravky.

Potvrzuji proto, že jsem zdravotnickým odborníkem ve smyslu zákona č. 40/1995 Sb. ve znění pozdějších předpisů a že jsem se seznámil(a) s definicí zdravotnického odborníka.